Details

Autor(en) / Beteiligte

• Osuna, Ester
• Baumgartner, Jeannine
• Wunderlin, Olivia
• Emery, Sophie
• Albermann, Mona
• Baumgartner, Noemi
• Schmeck, Klaus
• Walitza, Susanne
• Strumberger, Michael
• Hersberger, Martin
• Zimmermann, Michael B.
• Häberling, Isabelle
• Berger, Gregor
• Herter-Aeberli, Isabelle

Titel

Iron status in Swiss adolescents with paediatric major depressive disorder and healthy controls: a matched case–control study

Ist Teil von

• European journal of nutrition, 2024-04, Vol.63 (3), p.951-963

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2024

Quelle

MEDLINE

Beschreibungen/Notizen

• Purpose Depression is associated with low-grade systemic inflammation and impaired intestinal function, both of which may reduce dietary iron absorption. Low iron status has been associated with depression in adults and adolescents. In Swiss adolescents, we determined the associations between paediatric major depressive disorder (pMDD), inflammation, intestinal permeability and iron status. Methods This is a matched case–control study in 95 adolescents with diagnosed pMDD and 95 healthy controls aged 13–17 years. We assessed depression severity using the Children’s Depression Rating Scale-Revised. We measured iron status (serum ferritin (SF) and soluble transferrin receptor (sTfR)), inflammation (C-reactive protein (CRP) and alpha-1-acid-glycoprotein (AGP)), and intestinal permeability (intestinal fatty acid binding protein (I-FABP)). We assessed history of ID diagnosis and treatment with a self-reported questionnaire. Results SF concentrations did not differ between adolescents with pMDD (median (IQR) SF: 31.2 (20.2, 57.0) μg/L) and controls (32.5 (22.6, 48.3) μg/L, p  = 0.4). sTfR was lower among cases than controls (4.50 (4.00, 5.50) mg/L vs 5.20 (4.75, 6.10) mg/L, p  < 0.001). CRP, AGP and I-FABP were higher among cases than controls (CRP: 0.16 (0.03, 0.43) mg/L vs 0.04 (0.02, 0.30) mg/L, p  = 0.003; AGP: 0.57 (0.44, 0.70) g/L vs 0.52 (0.41, 0.67) g/L, p  = 0.024); I-FABP: 307 (17, 515) pg/mL vs 232 (163, 357) pg/mL, p  = 0.047). Of cases, 44% reported having a history of ID diagnosis compared to 26% among controls ( p  = 0.020). Finally, 28% of cases had iron treatment at/close to study inclusion compared to 14% among controls. Conclusion Cases had significantly higher systemic inflammation and intestinal permeability than controls but did not have lower iron status. Whether this is related to the higher rate of ID diagnosis and iron treatment in adolescents with depression is uncertain.